Trademark Overview
On Tuesday, April 18, 2023, a trademark application was filed for KUDO BIOWORKS with the United States Patent and Trademark Office. The USPTO has given the KUDO BIOWORKS trademark a serial number of 97893771. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, July 17, 2023. This trademark is owned by RVAC Medicines Pte. Ltd.. The KUDO BIOWORKS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions
Scientific and engineering research and manufacturing services relating to biotechnology and pharmaceutical products; development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagents, formulations such as lipids and lipid nanoparticles, and biologics; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of nucleic acid medicines; research and development of mRNA drug substance and drug products; biomedical research services; development of pharmaceutical preparations and medicines
